1 documents found
Information × Registration Number 0120U102875, R & D request Title A multicenter, randomized, double-blind, placebo-controlled, phase 3 study to evaluate oral ozanimod for induction therapy in patients with moderate to severe Crohn's disease in active form. Head Skrypnyk Ihor M., Доктор медичних наук Registration Date 16-06-2020 Organization Ukrainian medical stomatological Academy popup.description1 Phase 3 study to evaluate oral ozanimod during induction therapy in patients with moderate or severe Crohn's disease in active form popup.nrat_date 2024-12-10 Close
search.res_rk
A multicenter, randomized, double-blind, placebo-controlled, phase 3 study to evaluate oral ozanimod for induction therapy in patients with moderate to severe Crohn's disease in active form.
Head: Skrypnyk Ihor M.. A multicenter, randomized, double-blind, placebo-controlled, phase 3 study to evaluate oral ozanimod for induction therapy in patients with moderate to severe Crohn's disease in active form.. Ukrainian medical stomatological Academy. № 0120U102875
1 documents found

Updated: 2026-03-26


Роздрукувати цю сторінку